These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9036753)
1. Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. Barr CS; Naas AA; Fenwick M; Struthers AD Am J Cardiol; 1997 Feb; 79(3):328-33. PubMed ID: 9036753 [TBL] [Abstract][Full Text] [Related]
2. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure. Cleland JG; Gillen G; Dargie HJ Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173 [TBL] [Abstract][Full Text] [Related]
3. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. Hall D; Zeitler H; Rudolph W J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929 [TBL] [Abstract][Full Text] [Related]
4. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283 [TBL] [Abstract][Full Text] [Related]
5. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Sigurdsson A Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749 [TBL] [Abstract][Full Text] [Related]
6. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. MacFadyen RJ; Lees KR; Reid JL Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084 [TBL] [Abstract][Full Text] [Related]
7. Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure. Coats AJ; Adamopoulos S Cardiovasc Drugs Ther; 1994 Oct; 8(5):685-92. PubMed ID: 7873465 [TBL] [Abstract][Full Text] [Related]
10. Enalapril and QTC dispersion in congestive heart failure. Brockmeier LB Am J Cardiol; 1997 Dec; 80(12):1643. PubMed ID: 9416960 [No Abstract] [Full Text] [Related]
11. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753 [TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators. Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661 [TBL] [Abstract][Full Text] [Related]
13. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698 [TBL] [Abstract][Full Text] [Related]
14. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864 [TBL] [Abstract][Full Text] [Related]
15. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904 [TBL] [Abstract][Full Text] [Related]
16. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. González-Juanatey JR; García-Acuña JM; Pose A; Varela A; Calvo C; Cabezas-Cerrato J; de la Peña MG Am J Cardiol; 1998 Jan; 81(2):170-4. PubMed ID: 9591900 [TBL] [Abstract][Full Text] [Related]
17. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Magri P; Rao MA; Cangianiello S; Bellizzi V; Russo R; Mele AF; Andreucci M; Memoli B; De Nicola L; Volpe M Circulation; 1998 Dec 22-29; 98(25):2849-54. PubMed ID: 9860786 [TBL] [Abstract][Full Text] [Related]
18. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity]. Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415 [TBL] [Abstract][Full Text] [Related]
19. Concurrent alpha 1 adrenergic blockade and angiotensin converting enzyme inhibition in the treatment of congestive heart failure. Ajayi AA; Sofowora GG; Balogun MO Int J Cardiol; 1996 Dec; 57(2):173-6. PubMed ID: 9013270 [TBL] [Abstract][Full Text] [Related]
20. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Guazzi M; Melzi G; Agostoni P Am J Cardiol; 1997 Dec; 80(12):1572-6. PubMed ID: 9416938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]